Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Addict Biol. 2021 Aug 31;27(1):e13092. doi: 10.1111/adb.13092

TABLE 2.

Means, standard deviations, and zero-order correlations between plasma cannabinoids and subjective effects at the acute post-use assessment time point

Variable M SD 1 2 3 4 5 6 7 8 9 10
1. THC (ng/ml) 102.20 186.73
2. THCV (ng/ml) 0.20 0.61 .69***
3. CBN (ng/ml) 2.95 4.71 .73*** .59***
4. CBG (ng/ml) 2.49 3.44 .77*** .70*** .73***
5. CBD (ng/ml) 38.22 67.59 .03 .26** .15 .49***
6. CBC (ng/ml) 13.16 16.10 .43*** .45*** .43*** .73*** .77***
7. Subjective high 3.38 1.27 .11 .05 .08 −.02 −.20* −.16
8. Elation 1.16 1.07 .04 .01 .08 −.03 −.15 −.18* .35***
9. Drug liking 3.70 0.95 .07 .08 .10 .07 .01 −.01 .38*** .33***
10. Anxiety/tension 0.36 0.45 −.02 −.11 −.16 −.07 .01 .05 .14 −.04 −.12
11. Paranoia 0.21 0.51 .02 −.03 −.08 −.13 −.16 −.12 .20* .03 −.05 .61***

Note: M and SD are used to represent mean and standard deviation, respectively.

*

p < .05.

**

p < .01.

***

p < .001.